Evidence map›Paper›PMID 36757570›Full record

ArticleArchives of virology2023

Molecular characterization of a novel victorivirus (order Ghabrivirales, family Totiviridae) infecting Metarhizium anisopliae.

Matheus da Silva Camargo, Felipe Geremia, Nicolau Sbaraini, Charley Christian Staats, Marcio Silva Filho, Augusto Schrank

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Matheus da Silva CamargoBiotechnology Center, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Felipe GeremiaBiotechnology Center, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Nicolau SbarainiSchool of Molecular Sciences, The University of Western Australia, Perth, WA, 6009, Australia.
Charley Christian StaatsBiotechnology Center, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Marcio Silva FilhoDepartment of Genetics, ESALQ, Universidade de São Paulo, Piracicaba, Brazil.
Augusto SchrankBiotechnology Center, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. aschrank@ufrgs.br.ORCID http://orcid.org/0000-0002-5248-4620
Universidade Federal do Rio Grande do Sul · BRThe University of Western Australia · AUUniversidade de São Paulo · BR

Funding

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul 41172.541.29362.15072019
6 · The paper itself

Abstract

Here, we report the occurrence and complete genome sequence of a novel victorivirus infecting Metarhizium anisopliae, named "Metarhizium anisopliae victorivirus 1" (MaVV1). The genome is 5353 bp in length and contains two open reading frames (ORFs), encoding a coat protein and an RNA-dependent RNA polymerase (RdRp), that overlap at the octanucleotide sequence AUGAGUAA. These ORFs showed sequence similarity to the corresponding ORFs of Ustilaginoidea virens RNA virus L (68.23%) and Ustilaginoidea virens RNA virus 13 (58.11%), respectively, both of which belong to the family Totiviridae. Phylogenetic analysis based on RdRp sequences revealed that MaVV1 clustered with members of the genus Victorivirus. This is the first genome sequence reported for a virus belonging to the genus Victorivirus infecting the entomopathogenic fungus M. anisopliae.

Indexed as

Genome, ViralMetarhiziumTotiviridaeHypocrealesOpen Reading FramesPhylogenyRNA-Dependent RNA PolymeraseRNA, Double-StrandedRNA, ViralRNA-Dependent RNA PolymeraseRNA, Double-StrandedRNA, Viral

Identifiers

PMID36757570
OpenAlexW4319655566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.